| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Evolus (NASDAQ:EOLS) reported its Q4 earnings results on Thursday, March 7, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Evolus missed estimated earnings by -200.0%, reporting an EPS of $-0.21 versus an estimate of $-0.07.
Revenue was up $17.35 million from the same period last year.
Last quarter the company missed on EPS by $0.13 which was followed by a 8.0% increase in the share price the next day.
Here's a look at Evolus's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.17 | -0.22 | -0.15 | -0.15 |
| EPS Actual | -0.30 | -0.32 | -0.26 | -0.23 |
| Revenue Estimate | 45.02M | 64.12M | 40.69M | 43.79M |
| Revenue Actual | 50.02M | 49.35M | 41.72M | 43.65M |
To track all earnings releases for Evolus visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: EOLS
